Cargando…
Idiopathic (primary) achalasia
Idiopathic achalasia is a primary esophageal motor disorder characterized by esophageal aperistalsis and abnormal lower esophageal sphincter (LES) relaxation in response to deglutition. It is a rare disease with an annual incidence of approximately 1/100,000 and a prevalence rate of 1/10,000. The di...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040141/ https://www.ncbi.nlm.nih.gov/pubmed/17894899 http://dx.doi.org/10.1186/1750-1172-2-38 |
_version_ | 1782137070796406784 |
---|---|
author | Farrokhi, Farnoosh Vaezi, Michael F |
author_facet | Farrokhi, Farnoosh Vaezi, Michael F |
author_sort | Farrokhi, Farnoosh |
collection | PubMed |
description | Idiopathic achalasia is a primary esophageal motor disorder characterized by esophageal aperistalsis and abnormal lower esophageal sphincter (LES) relaxation in response to deglutition. It is a rare disease with an annual incidence of approximately 1/100,000 and a prevalence rate of 1/10,000. The disease can occur at any age, with a similar rate in men and women, but is usually diagnosed between 25 and 60 years. It is characterized predominantly by dysphagia to solids and liquids, bland regurgitation, and chest pain. Weight loss (usually between 5 to 10 kg) is present in most but not in all patients. Heartburn occurs in 27%–42% of achalasia patients. Etiology is unknown. Some familial cases have been reported, but the rarity of familial occurrence does not support the hypothesis that genetic inheritance is a significant etiologic factor. Association of achalasia with viral infections and auto-antibodies against myenteric plexus has been reported, but the causal relationship remains unclear. The diagnosis is based on history of the disease, radiography (barium esophagogram), and esophageal motility testing (esophageal manometry). Endoscopic examination is important to rule out malignancy as the cause of achalasia. Treatment is strictly palliative. Current medical and surgical therapeutic options (pneumatic dilation, surgical myotomy, and pharmacologic agents) aimed at reducing the LES pressure and facilitating esophageal emptying by gravity and hydrostatic pressure of retained food and liquids. Although it cannot be permanently cured, excellent palliation is available in over 90% of patients. |
format | Text |
id | pubmed-2040141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20401412007-10-23 Idiopathic (primary) achalasia Farrokhi, Farnoosh Vaezi, Michael F Orphanet J Rare Dis Review Idiopathic achalasia is a primary esophageal motor disorder characterized by esophageal aperistalsis and abnormal lower esophageal sphincter (LES) relaxation in response to deglutition. It is a rare disease with an annual incidence of approximately 1/100,000 and a prevalence rate of 1/10,000. The disease can occur at any age, with a similar rate in men and women, but is usually diagnosed between 25 and 60 years. It is characterized predominantly by dysphagia to solids and liquids, bland regurgitation, and chest pain. Weight loss (usually between 5 to 10 kg) is present in most but not in all patients. Heartburn occurs in 27%–42% of achalasia patients. Etiology is unknown. Some familial cases have been reported, but the rarity of familial occurrence does not support the hypothesis that genetic inheritance is a significant etiologic factor. Association of achalasia with viral infections and auto-antibodies against myenteric plexus has been reported, but the causal relationship remains unclear. The diagnosis is based on history of the disease, radiography (barium esophagogram), and esophageal motility testing (esophageal manometry). Endoscopic examination is important to rule out malignancy as the cause of achalasia. Treatment is strictly palliative. Current medical and surgical therapeutic options (pneumatic dilation, surgical myotomy, and pharmacologic agents) aimed at reducing the LES pressure and facilitating esophageal emptying by gravity and hydrostatic pressure of retained food and liquids. Although it cannot be permanently cured, excellent palliation is available in over 90% of patients. BioMed Central 2007-09-26 /pmc/articles/PMC2040141/ /pubmed/17894899 http://dx.doi.org/10.1186/1750-1172-2-38 Text en Copyright © 2007 Farrokhi and Vaezi; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Farrokhi, Farnoosh Vaezi, Michael F Idiopathic (primary) achalasia |
title | Idiopathic (primary) achalasia |
title_full | Idiopathic (primary) achalasia |
title_fullStr | Idiopathic (primary) achalasia |
title_full_unstemmed | Idiopathic (primary) achalasia |
title_short | Idiopathic (primary) achalasia |
title_sort | idiopathic (primary) achalasia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040141/ https://www.ncbi.nlm.nih.gov/pubmed/17894899 http://dx.doi.org/10.1186/1750-1172-2-38 |
work_keys_str_mv | AT farrokhifarnoosh idiopathicprimaryachalasia AT vaezimichaelf idiopathicprimaryachalasia |